Redwood Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-122,270
Closed -$621K 333
2024
Q1
$621K Buy
+122,270
New +$621K 0.06% 276